Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer

Lung cancer is a malignant tumor with the highest mortality in the world. The most common pathological type of lung cancer is non-small cell lung cancer (NSCLC). In recent years, immunotherapy has brought about epoch-making changes in the treatment of NSCLC. In particular, immune checkpoint inhibito...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chuan HUANG, Xue YANG
Formato: article
Lenguaje:ZH
Publicado: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021
Materias:
Acceso en línea:https://doaj.org/article/ae484970d4ee4d4ab5327fcf84f9f91a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!